Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis
Authors:
- 29 March 2007
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 114 (6) , 845-849
Abstract
We have developed several series of potent and selective small molecule inhibitors of SSAO (AOC3/VAP-1) that also block trafficking of leukocytes to sites of inflammation. Blocking of SSAO-mediated leukocyte adhesion has recently been shown efficacious in several models of inflammatory diseases. We have examined the potential of SSAO inhibitors in neurological diseases, having previously demonstrated the efficacy of SSAO inhibition in a rat model of stroke. Here we show the effect of the small molecule SSAO inhibitor LJP 1207 (IC50 human SSAO 17 nM; ratio IC50 SSAO:MAO >5000), on relapsing-remitting experimental autoimmune encephalomyelitis (EAE), a mouse model that shares many characteristics with human multiple sclerosis. Clinical efficacy was observed when dosing with LJP 1207 was initiated either at the peak of initial flare or during remission. These data demonstrate the potential clinical benefit of small molecule anti-SSAO therapy in this model.Keywords
This publication has 20 references indexed in Scilit:
- Vascular Adhesion Protein-1 Plays an Important Role in Postischemic Inflammation and Neuropathology in Diabetic, Estrogen-Treated Ovariectomized Female Rats Subjected to Transient Forebrain IschemiaThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Design, Synthesis, and Biological Evaluation of Semicarbazide-Sensitive Amine Oxidase (SSAO) Inhibitors with Anti-inflammatory ActivityJournal of Medicinal Chemistry, 2006
- Multiple Sclerosis — The Plaque and Its PathogenesisNew England Journal of Medicine, 2006
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Blocking adhesion molecules as therapy for multiple sclerosis: natalizumabNature Reviews Drug Discovery, 2005
- Therapeutic Intervention in Inflammatory Diseases: A Time and Place for Anti‐Adhesion TherapyMicrocirculation, 2005
- Absence of the Endothelial Oxidase AOC3 Leads to Abnormal Leukocyte Traffic In VivoImmunity, 2005
- Discordant effects of anti–VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitisJournal of Clinical Investigation, 2001
- A Cell Surface Amine Oxidase Directly Controls Lymphocyte MigrationImmunity, 2001
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992